Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance

Current Opinion in Pharmacology

Volumn 7, Issue 4, 2007, Pages 367-374

  Lo, Hui Wen ^a   Ali Osman, Francis ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ALANINE; ANTINEOPLASTIC AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1; BROSTALLICIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETACRYNIC ACID; FANCONI ANEMIA GROUP C PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; IFOSFAMIDE; ISOLEUCINE; MELPHALAN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; THIOTEPA; UNINDEXED DRUG; VALINE;

AMINO ACID SUBSTITUTION; APOPTOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL ACTIVITY; CELL METABOLISM; CELL PROLIFERATION; DISEASE FREE SURVIVAL; DRUG METABOLISM; ENZYME ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; STRESS; TREATMENT OUTCOME; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; NEOPLASMS; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 34548067158     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.06.009     Document Type: Review

References (74)

1. Johansson A.-S., and Mannervik B. Interindividual variability of glutathione transferase expression. In: Pacifici G.M., and Pelkonen O. (Eds). Interindividual Variability in Human Drug Metabolism (2001), Taylor & Francis, London 460-519
2. Johansson K., Ahlen K., Rinaldi R., Sahlander K., Siritantikorn A., and Morgenstern R. Microsomal glutathione transferase 1 in anticancer drug resistance. Carcinogenesis 28 (2007) 465-470
3. Jowsey I.R., Thomson R.E., Orton T.C., Elcombe C.R., and Hayes J.D. Biochemical and genetic characterization of a murine class Kappa glutathione S-transferase. Biochem J 373 (2003) 559-569
4. Morel F., Rauch C., Petit E., Piton A., Theret N., Coles B., and Guillouzo A. Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem 279 (2004) 16246-16253
5. Boyland E., and Chasseaud L.F. The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis. Adv Enzymol Relat Areas Mol Biol 32 (1969) 173-219
6. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 45 (2005) 51-88
7. Chen H., and Juchau M.R. Biotransformation of 13-cis- and 9-cis-retinoic acid to all-trans-retinoic acid in rat conceptal homogenates. Evidence for catalysis by a conceptal isomerase. Drug Metab Dispos 26 (1998) 222-228
8. Tew K.D. Glutathione-associated Enzymes in Anticancer Drug Resistance. Cancer Res 54 (1994) 4313-4320
9. Ciaccio P.J., Tew K.D., and LaCreta F.P. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem Pharmacol 42 (1991) 1504-1507
10. Kusama M., Kubota T., Matsukura Y., Matsuno K., Ogawa S., Kanda Y., and Iga T. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan. Clin Chim Acta 368 (2006) 93-98
11. Sharma A., Patrick B., Li J., Sharma R., Jeyabal P.V., Reddy P.M., Awasthi S., and Awasthi Y.C. Glutathione S-transferases as antioxidant enzymes: small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Arch Biochem Biophys 452 (2006) 165-173
12. Sweeney C., Ambrosone C.B., Joseph L., Stone A., Hutchins L.F., Kadlubar F.F., and Coles B.F. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer 103 (2003) 810-814
13. McIlwain C.C., Townsend D.M., and Tew K.D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25 (2006) 1639-1648
14. Ning B., Wang C., Morel F., Nowell S., Ratnasinghe D.L., Carter W., Kadlubar F.F., and Coles B. Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics 14 (2004) 35-44
15. Ross V.L., Board P.G., and Webb G.C. Chromosomal mapping of the human Mu class glutathione S-transferases to 1p13. Genomics 18 (1993) 87-91
16. Seidegard J., Vorachek W.R., Pero R.W., and Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 85 (1988) 7293-7297
17. Widersten M., Pearson W.R., Engstrom A., and Mannervik B. Heterologous expression of the allelic variant mu-class glutathione transferases mu and pi. Biochem J 276 Pt 2 (1991) 519-524
18. McLellan R.A., Oscarson M., Alexandrie A.K., Seidegard J., Evans D.A., Rannug A., and Ingelman-Sundberg M. Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol 52 (1997) 958-965
19. Evans D.A., Seidegard J., and Narayanan N. The GSTM1 genetic polymorphism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis. Pharmacogenetics 6 (1996) 365-367
20. Hall A.G., Autzen P., Cattan A.R., Malcolm A.J., Cole M., Kernahan J., and Reid M.M. Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia. Cancer Res 54 (1994) 5251-5254
21. Howells R.E., Holland T., Dhar K.K., Redman C.W., Hand P., Hoban P.R., Jones P.W., Fryer A.A., and Strange R.C. Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. Int J Gynecol Cancer 11 (2001) 107-112
22. Gonlugur U., Pinarbasi H., Gonlugur T.E., and Silig Y. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome. Cancer Invest 24 (2006) 497-501
23. Inskip A., Elexperu-Camiruaga J., Buxton N., Dias P.S., MacIntosh J., Campbell D., Jones P.W., Yengi L., Talbot J.A., Strange R.C., et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 312 Pt 3 (1995) 713-716
24. Berhane K., Hao X.Y., Egyhazi S., Hansson J., Ringborg U., and Mannervik B. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. Cancer Res 53 (1993) 4257-4261
25. Smith M.T., Evans C.G., Doane-Setzer P., Castro V.M., Tahir M.K., and Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 49 (1989) 2621-2625
26. Jungnelius U., Ridderstrom M., Hansson J., Ringborg U., and Mannervik B. Similar toxic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea on lymphocytes from human subjects differing in the expression of glutathione transferase M1-1. Biochem Pharmacol 47 (1994) 1777-1780
27. Ali-Osman F., Stein D.E., and Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res 50 (1990) 6976-6980
28. Holley S.L., Rajagopal R., Hoban P.R., Deakin M., Fawole A.S., Elder J.B., Elder J., Smith V., Strange R.C., and Fryer A.A. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer. Int J Oncol 28 (2006) 231-236
29. Board P.G., Webb G.C., and Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53 (1989) 205-213
30. Islam M.Q., Platz A., Szpirer J., Szpirer C., Levan G., and Mannervik B. Chromosomal localization of human glutathione transferase genes of classes alpha, mu and pi. Hum Genet 82 (1989) 338-342
31. Ishikawa T., and Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268 (1993) 20116-20125
32. Ishimoto T.M., and Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 12 (2002) 543-553
33. Goto S., Iida T., Cho S., Oka M., Kohno S., and Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res 31 (1999) 549-558
34. Oguchi H., Kikkawa F., Kojima M., Maeda O., Mizuno K., Suganuma N., Kawai M., and Tomoda Y. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Anticancer Res 14 (1994) 193-200
35. Yasuno T., Matsumura T., Shikata T., Inazawa J., Sakabe T., Tsuchida S., Takahata T., Miyairi S., Naganuma A., and Sawada T. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Anticancer Res 19 (1999) 4049-4057
36. Ali-Osman F., Brunner J.M., Kutluk T.M., and Hess K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res 3 (1997) 2253-2261
37. Ali-Osman F., Akande O., Antoun G., Mao J.X., and Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272 (1997) 10004-10012
38. Lo H.W., and Ali-Osman F. Genomic cloning of hGSTP1*C, an allelic human Pi class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem 272 (1997) 32743-32749
39. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., and Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19 (1998) 275-280
40. Pandya U., Srivastava S.K., Singhal S.S., Pal A., Awasthi S., Zimniak P., Awasthi Y.C., and Singh S.V. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun 278 (2000) 258-262
41. Srivastava S.K., Singhal S.S., Hu X., Awasthi Y.C., Zimniak P., and Singh S.V. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 366 (1999) 89-94
42. Ezer R., Alonso M., Pereira E., Kim M., Allen J.C., Miller D.C., and Newcomb E.W. Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol 59 (2002) 123-134
43. Goekkurt E., Hoehn S., Wolschke C., Wittmer C., Stueber C., Hossfeld D.K., and Stoehlmacher J. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients. Br J Cancer 94 (2006) 281-286
44. Oldenburg J., Kraggerud S.M., Cvancarova M., Lothe R.A., and Fossa S.D. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. J Clin Oncol 25 (2007) 708-714
45. Allan J.M., Wild C.P., Rollinson S., Willett E.V., Moorman A.V., Dovey G.J., Roddam P.L., Roman E., Cartwright R.A., and Morgan G.J. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukaemia. Proc Natl Acad Sci U S A 98 (2001) 11592-11597
46. Maggini V, Buda G, Galimberti S, Conidi E, Giuliani N, Morabito F, Genestreti G, Iacopino P, Rizzoli V, Barale R, et al.: Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms. Leuk. Res., in press.
47. Williams T.A., Mars A.E., Buyske S.G., Stenroos E.S., Wang R., Factura-Santiago M.F., Lambert G.H., and Johnson W.G. Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 161 (2007) 356-361
48. Okuyama T., Maehara Y., Endo K., Baba H., Adachi Y., Kuwano M., and Sugimachi K. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 74 (1994) 1230-1236
49. Townsend D.M., and Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22 (2003) 7369-7375
50. Ali-Osman F., Friedman H.S., Antoun G.R., Reardon D., Bigner D.D., and Buolamwini J.K. In: Ali-Osman F. (Ed). Rational Design and Development of Targeted Brain Tumor Therapeutics (2005), Humana Press, Totowa
51. Kavanagh J.J., Gershenson D.M., Choi H., Lewis L., Patel K., Brown G.L., Garcia A., and Spriggs D.R. Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Int J Gynecol Cancer 15 (2005) 593-600
52. Vergote I, Finkler N, del Campo J, Lohr A, Hunter J, Matei D, Spriggs D, Kavanagh J, Vermorken J, Brown GL, et al.: Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): Phase 3 study results. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S, No. LBA5528.
53. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., and Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300 Pt 1 (1994) 271-276
54. Tan K.L., Webb G.C., Baker R.T., and Board P.G. Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22. Genomics 25 (1995) 381-387
55. Sherratt P.J., Pulford D.J., Harrison D.J., Green T., and Hayes J.D. Evidence that human class Theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes Alpha, Mu and Pi GST in human. Biochem J 326 Pt 3 (1997) 837-846
56. Jemth P., and Mannervik B. Kinetic characterization of recombinant human glutathione transferase T1-1, a polymorphic detoxication enzyme. Arch Biochem Biophys 348 (1997) 247-254
57. Alexandrie A.K., Rannug A., Juronen E., Tasa G., and Warholm M. Detection and characterization of a novel functional polymorphism in the GSTT1 gene. Pharmacogenetics 12 (2002) 613-619
58. Coggan M., Whitbread L., Whittington A., and Board P. Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex. Biochem J 334 Pt 3 (1998) 617-623
59. Salagovic J., Kalina I., Habalova V., Hrivnak M., Valansky L., and Biros E. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 48 (1999) 465-471
60. Zhang Y., Yang L., Li R., Zhang L., Zhang M.R., and Xiao Z.J. The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia. Zhonghua Nei Ke Za Zhi 45 (2006) 213-216
61. Beeghly A., Katsaros D., Chen H., Fracchioli S., Zhang Y., Massobrio M., Risch H., Jones B., and Yu H. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100 (2006) 330-337
62. Okcu M.F., Selvan M., Wang L.E., Stout L., Erana R., Airewele G., Adatto P., Hess K., Ali-Osman F., Groves M., et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 10 (2004) 2618-2625
63. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60 (2000) 4053-4057
64. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R., et al. Regulation of JNK signaling by GSTp. EMBO J 18 (1999) 1321-1334
65. Bernardini S., Bellincampi L., Ballerini S., Ranalli M., Pastore A., Cortese C., and Federici G. Role of GST P1-1 in mediating the effect of etoposide on human neuroblastoma cell line Sh-Sy5y. J Cell Biochem 86 (2002) 340-347
66. Cho S.G., Lee Y.H., Park H.S., Ryoo K., Kang K.W., Park J., Eom S.J., Kim M.J., Chang T.S., Choi S.Y., et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276 (2001) 12749-12755
67. Gilot D., Loyer P., Corlu A., Glaise D., Lagadic-Gossmann D., Atfi A., Morel F., Ichijo H., and Guguen-Guillouzo C. Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation. J Biol Chem 277 (2002) 49220-49229
68. Wu Y., Fan Y., Xue B., Luo L., Shen J., Zhang S., Jiang Y., and Yin Z. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25 (2006) 5787-5800
69. Wang J., Otsuki T., Youssoufian H., Foe J.L., Kim S., Devetten M., Yu J., Li Y., Dunn D., and Liu J.M. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Res 58 (1998) 3538-3541
70. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., and Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 7 (2001) 814-820
71. Piredda L., Farrace M.G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., and Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. Faseb J 13 (1999) 355-364
72. Koh J., and Ali-Osman F. GSTP1 forms a stable, non-covalent complex with the tissue transglutaminase TGM2 in human glioblastoma cells. Proc Annu Meet Am Assoc Cancer Res 98 (2007) 4488
73. Lo H.W., Antoun G.R., and Ali-Osman F. The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells. Cancer Res 64 (2004) 9131-9138
74. Okamura T., Singh S., Haystead T., Bigner D., and Ali-Osman F. EGFR phosphorylates Glutathione S-Transferase P1 (GSTP1), a novel downstream target, in human glioma cells. Proc Annu Meet Am Assoc Cancer Res 97 (2006) 80